Michael Rink

Universität Hamburg — Germany

Medicine · Health Sciences

58h-index12.1kcitations549works4.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bladder and Urothelial Cancer Treatments(371), Urinary and Genital Oncology Studies(270), Urological Disorders and Treatments(138), Renal cell carcinoma treatment(66), Prostate Cancer Diagnosis and Treatment(58)

Publications548 total

Differential Androgen Receptor Expression Across Bladder Cancer Stages and Its Link to Poor Outcomes
Cancers·2025Open Access
Indeterminate Surgical Margins (Rx) in Renal Cell Carcinoma Surgery: Rates, Predictive Factors, and Impact on Overall Survival
Clinical Genitourinary Cancer·2025Open Access
Oncological outcomes of open versus minimally invasive nephroureterectomy for locally advanced upper tract urothelial carcinoma
World Journal of Urology·2025· 2 citedOpen Access
MTAP deficiency is highly homogeneous in advanced, muscle-invasive urothelial carcinoma of the urinary bladder
Scientific Reports·2025Open Access
Prevalence and Prognostic Significance of Preoperative Anemia in Radical Cystectomy Patients: A Multicenter Retrospective Observational Study
European Urology Open Science·2025· 1 citedOpen Access
KDM6A expression loss is frequent in low grade non-invasive urothelial carcinomas of the urinary bladder
Pathologica·2025· 1 citedOpen Access
Abstract 5860: Stimulator of interferon genes protein (STING) expression in tumor cells is linked to favorable disease parameters and a high density of tumor infiltrating inflammatory cells in urinary bladder cancer
Cancer Research·2025
IP24-21 A SYSTEMATIC REVIEW/META-ANALYSIS ON PERI-OPERATIVE STENTING/DWELL TIME AND POSTOPERATIVE OUTCOMES IN PATIENTS UNDERGOING RADICAL CYSTECTOMY AND URINARY DIVERSION FOR BLADDER CANCER
The Journal of Urology·2025
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines
European Urology·2025· 103 citedOpen Access
A Prospective Non-interventional Real-World Study of cabozantinib in Pretreated Patients With Advanced Renal Cell Carcinoma Refractory to Vascular Endothelial Growth Factor-Targeted Therapy (CASSIOPE)
Clinical Genitourinary Cancer·2024Open Access
Corrigendum to “European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines” [Eur. Urol. 85 (2024) 17–31]
Carolina Digital Repository (University of North Carolina at Chapel Hill)·2024Open Access
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
Carolina Digital Repository (University of North Carolina at Chapel Hill)·2024· 2 citedOpen Access
Reduced p63 expression is linked to unfavourable prognosis in muscle‐invasive urothelial carcinoma of the bladder
BJUI Compass·2024Open Access
17p13 (<i>TP53</i>) Deletions Are Associated With an Aggressive Phenotype but Unrelated to Patient Prognosis in Urothelial Bladder Carcinomas
Genes Chromosomes and Cancer·2024· 2 citedOpen Access
Thromboprophylaxis during neoadjuvant chemotherapy for bladder cancer reduces thromboembolism and bleeding
British Journal of Urology·2024Open Access
MP15-17 HIGH ANDROGEN RECEPTOR EXPRESSION IS LINKED TO POOR PROGNOSIS IN MALE PATIENTS WITH MUSCLE-INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER
The Journal of Urology·2024
PD-L1 expression in tumor and inflammatory cells is associated with favorable tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of the bladder not treated by immune checkpoint inhibitors
BMC Urology·2024· 2 citedOpen Access
PD34-12 THE OPTIMAL NUMBER OF INDUCTION CHEMOTHERAPY CYCLES IN CLINICALLY LYMPH NODE-POSITIVE BLADDER CANCER
The Journal of Urology·2024
PD20-07 ONCOLOGIC OUTCOMES IN PATIENTS WITH VARIANT HISTOLOGIES OF UPPER TRACT UROTHELIAL CANCER: RESULTS FROM AN INTERNATIONAL MULTICENTER COHORT
The Journal of Urology·2024
CEA (CEACAM5) expression is common in muscle‐invasive urothelial carcinoma of the bladder but unrelated to the disease course
BJUI Compass·2024· 4 citedOpen Access
page 1 of 28Next →

Frequent Co-authors

Shahrokh F. Shariat(37), Évanguelos Xylinas(20), Pierre I. Karakiewicz(20), Yair Lotan(17), Douglas S. Scherr(14), Felix K.‐H. Chun(14), Morgan Rouprêt(11), Harun Fajković(10), Giacomo Novara(10), Armin Pycha(10), K. Eugene(9), Vitaly Margulis(9), Wassim Kassouf(8), Luis A. Kluth(8), Marko Babjuk(7), Jay D. Raman(7), Francesco Montorsi(6), Florian Roghmann(6), Marek Babjuk(6), Alberto Briganti(6)